Dogwood Therapeutics Inc.

Last updated September 27, 2026

Organization details

Legal name
Dogwood Therapeutics Inc.
Former names
Virios Therapeutics, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Alpharetta
Headquarters state / province
Georgia
Headquarters country
United States
Fiscal year end
December
Ticker symbol
DWTX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001818844
EIN
85-4314201

Board of directors

Chief executives

Gregory Scott Duncan · CHIEF EXECUTIVE OFFICER
Dates unknown

Director election results

Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

1 of this board's directors also sit on 1 other board. 1 is in the same sector.

Network of Dogwood Therapeutics Inc.'s board connections CorMedix Inc. CorMedix Inc. Gregory Scott Duncan Gregory Scott Duncan Dogwood Therapeutics Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 26, 2026 Sealbond Ltd Director, 10% owner, See Remarks Grant or award +4,098,360 $1.22 $4,999,999
Nov 21, 2025 Conjoint Inc. Director, 10% owner, See Remarks Derivative conversion +21,610,950 — —
Nov 21, 2025 Conjoint Inc. Director, 10% owner, See Remarks Derivative conversion +2,842,638 — —
Aug 21, 2023 William Pridgen Director Open-market purchase +15,335 $1.30 $19,936
Aug 17, 2023 Gregory Scott Duncan Director, Officer (CHIEF EXECUTIVE OFFICER) Open-market purchase +25,000 $1.25 $31,250

Organizations in the same sector, closest in location and size first.

Questions about Dogwood Therapeutics Inc.

Who is the CEO of Dogwood Therapeutics Inc.?

Gregory Scott Duncan is Dogwood Therapeutics Inc.'s CHIEF EXECUTIVE OFFICER.

How many directors are on Dogwood Therapeutics Inc.'s board?

Dogwood Therapeutics Inc.'s board has 9 directors: David R. Keefer, Gregory Scott Duncan, John C. Thomas, Kean Meng Melvin Toh, La Rosa Abel De, Richard Alan Burch, Richard James Whitley, William Pridgen and Ying Choi Alan Abel Yu.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="dogwood-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.